Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
56.70
-0.20 (-0.35%)
Feb 11, 2026, 1:30 PM CST

TPEX:4747 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
567.06611.42606.71494.67411.49424.02
Revenue Growth (YoY)
-8.29%0.78%22.65%20.21%-2.95%-0.31%
Cost of Revenue
337.44363.45362.08290.29239.57231.83
Gross Profit
229.62247.97244.63204.38171.92192.18
Selling, General & Admin
129.71129.21128.45108.45100.72103.57
Research & Development
19.4620.7617.2713.258.9213.08
Operating Expenses
148.94149.77145.8122.58109.64116.17
Operating Income
80.6898.298.8381.7962.2976.01
Interest Expense
-3.6-3.51-4.6-1.06-1.08-0.79
Interest & Investment Income
13.9813.246.330.490.570.99
Currency Exchange Gain (Loss)
0.070.130.040.1-0.66-0.02
Other Non Operating Income (Expenses)
3.810.650.280.210.830.33
EBT Excluding Unusual Items
94.95108.71100.8881.5361.9576.51
Gain (Loss) on Sale of Assets
-0.08-0.01--0.010.05
Pretax Income
95.38108.71100.8981.5361.9476.55
Income Tax Expense
19.0224.5921.1916.6812.8412.99
Net Income
76.3584.1279.764.8549.163.56
Net Income to Common
76.3584.1279.764.8549.163.56
Net Income Growth
-6.69%5.55%22.90%32.08%-22.75%-1.41%
Shares Outstanding (Basic)
454536303030
Shares Outstanding (Diluted)
474738303030
Shares Change (YoY)
-0.01%22.56%26.25%-0.07%-0.04%0.01%
EPS (Basic)
1.701.872.242.161.642.12
EPS (Diluted)
1.681.862.182.161.632.11
EPS Growth
-8.04%-14.69%0.88%32.52%-22.75%-1.40%
Free Cash Flow
35.2249.68103.8429.9815.06-90.41
Free Cash Flow Per Share
0.761.072.731.000.50-3.00
Dividend Per Share
1.7501.7501.5002.0001.4501.920
Dividend Growth
16.67%16.67%-25.00%37.93%-24.48%6.67%
Gross Margin
40.49%40.56%40.32%41.32%41.78%45.32%
Operating Margin
14.23%16.06%16.29%16.54%15.14%17.93%
Profit Margin
13.46%13.76%13.14%13.11%11.93%14.99%
Free Cash Flow Margin
6.21%8.13%17.11%6.06%3.66%-21.32%
EBITDA
101119.17119.94100.0677.5789.24
EBITDA Margin
17.81%19.49%19.77%20.23%18.85%21.05%
D&A For EBITDA
20.3220.9721.1118.2715.2913.23
EBIT
80.6898.298.8381.7962.2976.01
EBIT Margin
14.23%16.06%16.29%16.54%15.14%17.93%
Effective Tax Rate
19.95%22.62%21.00%20.46%20.73%16.97%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.